Table 2 The most cited articles
From: A world map of esophagus cancer research: a critical accounting
Country | Authors | Years | Citations | Title |
|---|---|---|---|---|
USA | Devesa et al. | 1998 | 1484 | Changing patterns in the incidence of esophageal and gastric carcinoma in the United States |
South Korea, Belgium, Switzerland, China, Japan, Germany, Italy, Russia, Australia | Bang et al. | 2010 | 1312 | Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial |
USA | Herskovic et al. | 1992 | 1301 | Combined chemotherapy and radiotherapy compared with radiotherapie alone in patients with cancer of the esophagus |
Netherlands | van Hagen et al. | 2012 | 1117 | Preoperative chemoradiotherapy for esophageal or junctional cancer |
UK | Cunningham et al. | 2008 | 1025 | Capecitabine and oxaliplatin for advanced esophagogastric cancer |
France, Belgium | Bosset et al. | 1997 | 898 | Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus |
USA | Cooper et al. | 1999 | 872 | Chemoradiotherapy of locally advanced esophageal cancer—long-term follow-up of a prospective randomized trial (RTOG 85-01) |
France | Mandard et al. | 1994 | 842 | Pathological assessment of tumor-regression after preoperative chemoradiotherapy of esophageal-carcinoma |
USA, Canada | Kelsen et al. | 1998 | 837 | Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer |
USA | Urba et al. | 2001 | 813 | Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma |